Quantitative Systematic Strategies LLC Jounce Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 15, 2019
SELL
$3.43 - $6.87 $52,118 - $104,389
-15,195 Closed
0 $0
Q4 2018

Feb 12, 2019
BUY
$2.69 - $6.71 $40,874 - $101,958
15,195 New
15,195 $51,000
Q3 2018

Nov 14, 2018
SELL
$6.5 - $8.37 $69,043 - $88,906
-10,622 Closed
0 $0
Q2 2018

Aug 07, 2018
BUY
$7.27 - $21.88 $77,221 - $232,409
10,622 New
10,622 $81,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email